LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.21 | 21.74 | 730 | 392 | 1.8622 | 1.3214 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.21 | 21.74 | 1011 | 392 | 2.5791 | 1.5098 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 8.19 | 21.74 | 841 | 439 | 1.9120 | 1.3222 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 8.19 | 21.74 | 1092 | 439 | 2.4826 | 1.4663 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.16 | 21.74 | 901 | 463 | 1.9433 | 1.3248 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.16 | 21.74 | 18 | 463 | 0.0388 | -0.0419 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.16 | 21.74 | 1164 | 463 | 2.5106 | 1.4637 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.13 | 21.74 | 2 | 496 | 0.0040 | -0.4106 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.13 | 21.74 | 912 | 496 | 1.8374 | 1.2886 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.13 | 21.74 | 67 | 496 | 0.1350 | 0.2833 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.13 | 21.74 | 1206 | 496 | 2.4297 | 1.4348 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.10 | 21.74 | 2 | 540 | 0.0037 | -0.4022 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.10 | 21.74 | 995 | 540 | 1.8394 | 1.2809 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.10 | 21.74 | 158 | 540 | 0.2921 | 0.5338 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 14.10 | 21.74 | 1303 | 540 | 2.4088 | 1.4175 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.07 | 21.74 | 3 | 597 | 0.0050 | -0.3391 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.07 | 21.74 | 1104 | 597 | 1.8466 | 1.2737 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.07 | 21.74 | 267 | 597 | 0.4466 | 0.6897 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.07 | 21.74 | 1404 | 597 | 2.3484 | 1.3910 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.04 | 21.74 | 35 | 750 | 0.0466 | 0.0977 | MN20160310_N01 | E09 |